|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/28 | |
| A61P 35/00 | |||
| A61K 31/47 | |||
| A61K 31/337 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2296645 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09751682.7 |
| Europos patento paraiškos padavimo data | 2009-05-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-11-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/045029 |
| Data | 2009-05-22 |
| (87) | Numeris | WO 2009/143454 |
| Data | 2009-11-26 |
| (30) | Numeris | Data | Šalis |
| 55418 P | 2008-05-22 | US |
| (72) |
KEENE, Jeffery, L., US
RILEY, Dennis, P., US
BEARDSLEY, Robert, A., US
|
| (73) |
Galera Therapeutics, LLC,
101 Lindenwood Drive, Suite 405, Malvern, PA 19355,
US
|
| (54) | COMBINATION ANTITUMOR THERAPY |
| COMBINATION ANTITUMOR THERAPY |